KR7290650001
KR7290650001
L&C BIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.44T EUR | 2.31T EUR | 1.78T EUR | 1.54T EUR |
Enterprise Value | 1.52T EUR | 2.34T EUR | 1.83T EUR | 1.6T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 12.34x | 19.85x | 18.16x | 22.66x |
Price to Book | -- | 7.11x | 8.78x | 7.75x |
EV/Revenue | 13.1x | 20.09x | 18.61x | 23.56x |
EV/EBITDA | 55.55x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -3.17% | -0.37% | -0.25% | -0.32% |